99 related articles for article (PubMed ID: 18777298)
21. Field safety and efficacy of in ovo administration of HVT + SB-1 bivalent Marek's disease vaccine in commercial broilers.
Sarma G; Greer W; Gildersleeve RP; Murray DL; Miles AM
Avian Dis; 1995; 39(2):211-7. PubMed ID: 7677641
[TBL] [Abstract][Full Text] [Related]
22. Effect of maternal immunity against development of Marek's disease and protective ability of vaccine.
Yoshida I; Yuasa N; Horiuchi T; Tsubahara H
Natl Inst Anim Health Q (Tokyo); 1975; 15(1):1-7. PubMed ID: 804667
[TBL] [Abstract][Full Text] [Related]
23. Marek's disease control: comparative efficacy of cell-associated and cell-free lyophilized HVT vaccine.
Zanella A; Granelli G
Avian Pathol; 1974 Jan; 3(1):45-50. PubMed ID: 18777256
[TBL] [Abstract][Full Text] [Related]
24. Difference between influences of homologous and heterologous maternal antibodies on response to serotype-2 and serotype-3 Marek's disease vaccines.
King D; Page D; Schat KA; Calnek BW
Avian Dis; 1981; 25(1):74-81. PubMed ID: 6268052
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the efficacy against Marek's disease of cell-free and cell-associated turkey herpesvirus vaccine.
Eidson CS; Villegas P; Page RK; Kleven SH
Avian Dis; 1975; 19(3):515-24. PubMed ID: 1164319
[TBL] [Abstract][Full Text] [Related]
26. Effect of infectious bursal disease virus on protection against Marek's disease by turkey herpesvirus vaccine.
Sharma JM
Avian Dis; 1984; 28(3):629-40. PubMed ID: 6091603
[TBL] [Abstract][Full Text] [Related]
27. Kinetics of Marek's disease virus (MDV) infection in broiler chickens 1: effect of varying vaccination to challenge interval on vaccinal protection and load of MDV and herpesvirus of turkey in the spleen and feather dander over time.
Fakhrul Islam AF; Walkden-Brown SW; Groves PJ; Underwood GJ
Avian Pathol; 2008 Jun; 37(3):225-35. PubMed ID: 18568648
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous vaccination of day-old chickens against Newcastle and Marek's diseases.
Meulemans G; Vindevogel H; Halen P; Schyns P
Avian Pathol; 1974 Jan; 3(1):37-44. PubMed ID: 18777255
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV.
Geerligs HJ; Weststrate MW; Pertile TL; Rodenberg J; Kumar M; Chu S
Acta Virol; 1999; 43(2-3):198-200. PubMed ID: 10696445
[TBL] [Abstract][Full Text] [Related]
30. Differential effect of maternal antibodies on efficacy of cellular and cell-free Marek's disease vaccines.
Witter RL; Burmester BR
Avian Pathol; 1979 Apr; 8(2):145-56. PubMed ID: 18770437
[TBL] [Abstract][Full Text] [Related]
31. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
Kapczynski DR; King DJ
Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
[TBL] [Abstract][Full Text] [Related]
32. Quantitative pathogenicity of Marek's disease virus and vaccine virus strains in chickens: macroscopical aspects.
Maas HJ; Orthel FW; Rispens BH; Tittes EV; De Kort MF; Vreede-Groenewegen AE; Jansen J; Hartog L
Avian Pathol; 1978 Jan; 7(1):61-78. PubMed ID: 18770360
[TBL] [Abstract][Full Text] [Related]
33. Vaccination of commercial broiler chicks against avian metapneumovirus infection: a comparison of drinking-water, spray and oculo-oral delivery methods.
Ganapathy K; Bufton A; Pearson A; Lemiere S; Jones RC
Vaccine; 2010 May; 28(23):3944-8. PubMed ID: 20392431
[TBL] [Abstract][Full Text] [Related]
34. [Isolation of an avirulent strain of the chicken herpes virus type B].
Kasabov R; Nam LV
Vet Med Nauki; 1982; 19(7):81-8. PubMed ID: 7157664
[TBL] [Abstract][Full Text] [Related]
35. Serotype specificity of B-haplotype influence on the relative efficacy of Marek's disease vaccines.
Bacon LD; Witter RL
Avian Dis; 1994; 38(1):65-71. PubMed ID: 8002902
[TBL] [Abstract][Full Text] [Related]
36. [Methods for the control of avian tumour virus diseases (author's transl)].
de Boer GF
Tijdschr Diergeneeskd; 1977 Feb; 102(4):239-46. PubMed ID: 189455
[TBL] [Abstract][Full Text] [Related]
37. Expression of chicken interleukin-2 by turkey herpesvirus increases the immune response against Marek's disease virus but fails to increase protection against virulent challenge.
Tarpey I; Davis PJ; Sondermeijer P; van Geffen C; Verstegen I; Schijns VE; Kolodsick J; Sundick R
Avian Pathol; 2007 Feb; 36(1):69-74. PubMed ID: 17364512
[TBL] [Abstract][Full Text] [Related]
38. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.
Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S
Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546
[TBL] [Abstract][Full Text] [Related]
39. Comparison of intramuscular and subcutaneous administration of Marek's disease vaccine.
Oei HL; de Boer GF
Avian Pathol; 1986; 15(3):569-79. PubMed ID: 18766555
[TBL] [Abstract][Full Text] [Related]
40. Protective immunity to infectious bronchitis in broilers vaccinated against Marek's disease either in ovo or at hatch and against infectious bronchitis at hatch.
Avakian AP; Wakenell PS; Grosse D; Whitfill CE; Link D
Avian Dis; 2000; 44(3):536-44. PubMed ID: 11007000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
